Clinical significance of serum HBsAg levels and association with liver histology in HBeAg positive chronic hepatitis B

Journal of Clinical Virology

Volumn 57, Issue 4, 2013, Pages 323-330

  Cheng, Pin Nan ^a,b   Tsai, Hung Wen ^a,b   Chiu, Yen Cheng ^a,b   Ho, Cheng Hsun ^b   Wu, I Chin ^a,b   Chang, Ting Tsung ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Advanced liver fibrosis; Chronic hepatitis B; HBeAg; HBsAg level

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADULT; ANTIGEN EXPRESSION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL NUCLEUS; CLINICAL EVALUATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; FEMALE; GENE MUTATION; GENOTYPE; HEPATITIS B; HEPATITIS C; HUMAN; ISHAK SCORE; KNODELL SCORE; LIVER CELL; LIVER FIBROSIS; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ADULT; ANTIVIRAL AGENTS; DNA, VIRAL; FEMALE; HEPATITIS B CORE ANTIGENS; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HEPATOCYTES; HUMANS; INFLAMMATION; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MUTATION;

EID: 84879269775     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2013.04.012     Document Type: Article

References (27)

1. Ganem D., Prince A.M. Hepatitis B virus infection - natural history and clinical consequences. N Engl J Med 2004, 350:1118-1129.
2. Chan H.L., Sung J.J. Hepatocellular carcinoma and hepatitis B virus. Semin Liver Dis 2006, 26:153-161.
3. Brunetto M.R., Moriconi F., Bonino F., Lau G.K., Farci P., Yurdaydin C., et al. Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg negative chronic hepatitis B. Hepatology 2009, 49:1141-1150.
4. Moucari R., Mackiewicz V., Lada O., Ripault M.P., Castelnau C., Martinot-Peignoux M., et al. Early serum HBsAg drop: a strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients. Hepatology 2009, 49:1151-1157.
5. Sonneveld M.J., Rijckborst V., Boucher C.A., Hansen B.E., Janssen H.L. Prediction of sustained response to peginterferon alfa-2b for hepatitis B e antigen-positive chronic hepatitis B using on-treatment hepatitis B surface antigen decline. Hepatology 2010, 52:1251-1257.
6. Wursthorn K., Jung M., Riva A., Goodman Z.D., Lopez P., Bao W., et al. Kinetics of hepatitis B surface antigen decline during 3 years of telbivudine treatment in hepatitis B e antigen-positive patients. Hepatology 2010, 52:1611-1620.
7. Jaroszewicz J., Calle Serrano B., Wursthorn K., Deterding K., Schlue J., Raupach R., et al. Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective. J Hepatol 2010, 52:514-522.
8. Nguyen T., Thompson A.J., Bowden S., Croagh C., Bell S., Desmond P.V., et al. Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia. J Hepatol 2010, 52:508-513.
9. Hadziyannis S.J. Hepatitis B e antigen negative chronic hepatitis B: from clinical recognition to pathogenesis and treatment. Viral Hepat Rev 1995, 1:7-36.
10. Hadziyannis S.J., Vassilopoulos D. Hepatitis B e antigen negative chronic hepatitis B. Hepatology 2001, 34:617-624.
11. Wong G.L., Wong V.W., Choi P.C., Chan A.W., Chim A.M., Yiu K.K., et al. Clinical factors associated with liver stiffness in hepatitis B e antigen-positive chronic hepatitis B. Clin Gastroenterol Hepatol 2009, 7:227-233.
12. Liu W.C., Lindh M., Buti M., Phiet P.H., Mizokami M., Li H.H., et al. Genotyping of hepatitis B virus - genotypes a to g by multiplex polymerase chain reaction. Intervirology 2008, 51:247-252.
13. Knodell R.G., Ishak K.G., Black W.C., Chen T.S., Craig R., Kaplowitz N., et al. Formulation and application of a numerical scoring system for assessing histological activity inasymptomatic chronic active hepatitis. Hepatology 1981, 1:431-435.
14. Ishak K.G. Chronic hepatitis: morphology and nomenclature. Mod Pathol 1994, 7:690-713.
15. Chu C.M., Liaw Y.F. Immunohistological study of intrahepatic expression of hepatitis B core and E antigens in chronic type B hepatitis. J Clin Pathol 1992, 45:791-795.
16. Sugiyama M., Tanaka Y., Kato T., Orito E., Ito K., Acharya S.K., et al. Influence of hepatitis B virus genotypes on the intra- and extracellular expression of viral DNA and antigens. Hepatology 2006, 4:915-924.
17. Tuaillon E., Mondain A.M., Nagot N., Ottomani L., Kania D., Nogue E., et al. Comparison of serum HBsAg quantitation by four immunoassays, and relationships of HBsAg level with HBV replication and HBV genotypes. PLoS ONE 2012, 7:e32143.
18. Wursthorn K., Jaroszewicz J., Zacher B.J., Darnedde M., Raupach R., Mederacke I., et al. Correlation between the Elecsys HBsAg II assay and the architect assay for the quantification of hepatitis B surface antigen (HBsAg) in the serum. J Clin Virol 2011, 50:292-296.
19. Kao J.H., Wu N.H., Chen P.J., Lai M.Y., Chen D.S. Hepatitis B genotypes and the response to interferon therapy. J Hepatol 2000, 33:998-1002.
20. Choi M.S., Kim D.Y., Lee D.H., Lee J.H., Koh K.C., Paik S.W., et al. Clinical significance of pre-S mutations in patients with genotype C hepatitis B virus infection. J Viral Hepat 2007, 14:161-168.
21. Sugauchi F., Ohno T., Orito E., Sakugawa H., Ichida T., Komatsu M., et al. Influence of hepatitis B virus genotypes on the development of pre-S deletions and advanced liver disease. J Med Virol 2003, 70:537-544.
22. Lin C.L., Liu Ch, Wendy C., Huang W.L., Chen P.J., Lai M.Y., et al. Association of pre-S deletion mutant of hepatitis B virus with risk of hepatocellular carcinoma. J Gastroenterol Hepatol 2007, 22:1098-1103.
23. Wang H.C., Wu H.C., Chien C.F., Fausto N., Lei H.Y., Su I.J. Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific pre-S mutants that may induce endoplasmic reticulum stress. Am J Pathol 2003, 163:2441-2449.
24. Yang H.I., Yeh S.H., Chen P.J., Iloeje U.H., Jen C.L., Su J., et al. REVEAL-HBV study group. Associations between hepatitis B virus genotype and mutants and the risk of heptocellular carcinomain. J Natl Cancer Inst 2008, 100:1134-1143.
25. Chan H.L., Hui A.Y., Wong M.L.A., Tse M.-L.A.M.L., Hung L.C.T.L.C, Wong V.W., et al. Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma. Gut 2004, 53:1494-1498.
26. Thompson A.J., Nguyen T., Iser D., Ayres A., Jackson K., Littlejohn M., et al. Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers. Hepatology 2010, 51:1933-1944.
27. Serino Z., Varli M., Erden E., Cinar K., Kansu A., Uzunalimoglu O., et al. Nuclear localization of hepatitis B core antigen and its relations to liver injury, hepatocyte proliferation and viral load. J Clin Gastroenterol 2003, 36:269-272.